Startup profile · funding coverage
Marker Learning funding, valuation and investors
Digital health platform for remote learning-disability assessments — dyslexia, ADHD, dysgraphia.
Keep track of Marker Learning
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A
$15M · February 2023
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$15M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · New York, New York
Overview
Marker Learning is a digital health company providing remote assessments for learning disabilities including dyslexia, ADHD, and dysgraphia. Founded by dyslexia advocates, Marker partners with school districts to deliver evaluations faster and at lower cost than traditional in-person psychoeducational assessments. Marker raised a $15M Series A in February 2023 led by Andreessen Horowitz, with Primary Venture Partners and Virgin Group among participants.
Why Marker Learning is interesting
Marker founders were both diagnosed with dyslexia as kids — a16z-led $15M Series A (2023) scales school-district partnerships that cut assessment waitlists from months to weeks vs traditional psychoeducational evaluators.
Product & use cases
Marker delivers clinician-supervised remote evaluations for learning disabilities — combining standardized testing protocols, video assessment, and reporting that meets school district IEP requirements.
- School districts clearing assessment backlogs for special education eligibility
- Families accessing dyslexia/ADHD evaluations without months-long waitlists
- Remote psychoeducational testing in underserved districts lacking local evaluators
Key facts
- Series A (Feb 2023): $15M led by a16z (BusinessWire)
- Remote learning-disability assessments for school districts
- Founders both diagnosed with dyslexia in childhood
- Primary Venture Partners and Virgin Group among participants
Funding history (newest first)
Series A
2023-02 $15MSource: https://www.businesswire.com/news/marker-learning-series-a
Investors in our directory
Funds linked from Marker Learning's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Founder personal experience with dyslexia drives district trust and product design. Remote delivery collapses geographic access barriers that leave many students unassessed until years of struggle pass.
Special education assessment is regulated and district-contract driven. Marker must prove remote evaluations meet legal standards across states while scaling clinician network — a16z bet on edtech + healthtech intersection.
-
Traditional psychoeducational evaluators incumbent
In-person assessments with 6–12 month waitlists; Marker offers faster remote alternative.
-
Presence / teletherapy platforms adjacent
School teletherapy; overlapping district relationships but different service (therapy vs assessment).
-
Pearson clinical assessments incumbent
Assessment content/tools provider; Marker wraps delivery model around standard instruments.
Notable stories
- Marker's founders built the company from personal experience — both were diagnosed with dyslexia as children after years without support, motivating faster assessment access for the next generation.
- a16z's investment reflects edtech shift from consumer tutoring to district B2B infrastructure with Medicaid/IEP funding pathways.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Marker Learning's financing or category context.
FAQs about Marker Learning
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.